(MENAFN – PR Newswire) AlloJoin– is one of the few stem cell product candidates in late-stage clinical development worldwide ElpasBio is planning for data readout and NDA by next year ElpasBio. ..
(MENAFN – PR Newswire) AlloJoin– is one of the few stem cell product candidates in late-stage clinical development worldwide ElpasBio is planning for data readout and NDA by next year ElpasBio. ..